Showing 1,273 results

Filters Content type: News, Editors' picks Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

Gilead Sciences files for approval of cobicistat

Editor's pick
Bloomberg BusinessWeek
29 June 2012
The search for a cure

Four-class, five-drug regimen given to monkeys shows signs of producing long-term viral load reductions off treatment

News
29 June 2012
PrEP science

The road to PrEP: trials, regulation and roll-out

News
25 June 2012
Weight gain & lipodystrophy

Theratechnologies sinks on HIV drug setback

Editor's pick
Reuters
22 June 2012
New & experimental HIV treatments

European Medicines Agency Validates Gilead ’s Marketing Application for Elvitegravir for Treatment of HIV Infection

Editor's pick
Gilead press release
19 June 2012
New & experimental HIV treatments

New Drug-Screening Method Yields Long-Sought Anti-HIV Compounds

Editor's pick
Scripps Research Institute
15 June 2012
Undetectable viral load & treatment as prevention

Study shows that use of darunavir/ritonavir and etravirine in HIV treatment as a prevention method is biologically plausible

News
13 June 2012
New & experimental HIV treatments

UBC drug formulation receives $1.1 million for clinical development as HIV treatment

Editor's pick
EurekAlert (press release)
6 June 2012
New & experimental HIV treatments

Gilead Files European Marketing Application for Boosting Agent Cobicistat

Editor's pick
Gilead press release
25 May 2012
Drug interactions & pharmacokinetics

13th International workshop on Clinical Pharmacology of HIV Therapy 16–18 April 2012, Barcelona

Editor's pick
i-base
23 May 2012
New & experimental HIV treatments

Broad-Spectrum Antivirals: The Future of HIV Treatment?

Editor's pick
The Body
17 May 2012
New & experimental HIV treatments

FDA Panel Endorses 'Quad' Pill for HIV

Editor's pick
MedPage Today HIV/AIDS
14 May 2012
New & experimental HIV treatments

Gilead’s Quad Pill Raises Kidney Questions, FDA Says

Editor's pick
Bloomberg Business Week
9 May 2012
The search for a cure

Study using stem cell therapy shows promise in fight against HIV

Editor's pick
Eurekalert Inf Dis
3 May 2012
New & experimental hepatitis C treatment

No Relevant Interactions Between Telaprevir and Two Newest Nonnucleosides Rilpivirine & Etravirine

Editor's pick
NATAP
20 April 2012
New & experimental HIV treatments

Cobicistat Doubles to Triples Exposure of GS-7340 (a Tenofovir Prodrug) and Resulting Tenofovir

Editor's pick
NATAP
20 April 2012
Government, leadership & policy

Three Big HIV Days in May at the FDA

Editor's pick
AIDSMeds
19 April 2012
New & experimental HIV treatments

DFH Pharma to Collaborate with National Institutes of Health to Develop 2nd Generation HIV Maturation Inhibitor Drugs

Editor's pick
PR Newswire
16 April 2012
Side effects

CROI: Crofelemer Reduces Diarrhea in People with HIV; FDA Grants Priority Review

Editor's pick
HIVandHepatitis.com
13 April 2012
The search for a cure

Engineering CD8 Cells to Kill HIV in Tissues

Editor's pick
AIDSMeds
13 April 2012
Pharmaceutical industry

Gilead And The Future of HIV Therapy

Editor's pick
The Street
10 April 2012
New & experimental HIV treatments

GSK's new once-daily HIV drug matches Merck rival

Editor's pick
Reuters
2 April 2012
New & experimental HIV treatments

Shionogi-ViiV Healthcare Announces Initial Data from Pivotal Phase III Study

Editor's pick
ViiV Healthcare (press release)
2 April 2012
HIV treatment for children & young people

FDA Approves INTELENCE® (etravirine) Tablets for Treatment-Experienced Pediatric Patients with HIV-1

Editor's pick
Janssen press release
28 March 2012